CMS Dashes Industry Hopes For MCIT Rule Any Time Soon
Executive Summary
The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.
You may also be interested in...
CMS Mulls Proposal For Breakthrough Devices Almost One Year After MCIT Scrapped
A CMS official announced that the agency is working on a proposal to replace breakthrough device coverage scheme MCIT that will balance ensuring product safety with narrowing the “valley of death.”
AdvaMed Urges CMS To Leave MCIT In Place
In a letter to CMS Administrator Chiquita Brooks-LaSure, the industry association argues that repealing MCIT would deny many Americans access to “transformational” medical technologies.
Real-World Evidence Deemed Essential For Breakthrough Designations
A panel of experts in the health care and medical device industries discussed the fate of the Medicare Coverage for Innovative Technology (MCIT) rule during AdvaMed’s annual Medtech Conference.